{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:14:26Z","timestamp":1783779266852,"version":"3.55.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Based on the US FDA Adverse Event Reporting System, the adverse reaction (AE) signals of vancomycin in pediatric patients were mined, and its safety characteristics and risk association were evaluated. Data from 2004 to 2024 were extracted. The AE reports (n\u2005=\u200520,983) with vancomycin as the primary suspected drug were screened and standardized by MedDRA (version 26.1). Multi-algorithm fusion strategies were used to detect the signal intensity, and the effects of gender, age, and weight on AE distribution were analyzed. Male, 12 to 18 years old, weight\u2005\u226545\u2009kg; the US reported the most, and the main outcome was hospitalization. Skin and subcutaneous tissue disorders reported the most, while renal and urinary disorders have the strongest signal. Acute kidney injury is the most common, and linear immunoglobulin A disease has the highest signal intensity. Acute kidney injury is the main factor for both men and women. The\u2005&lt;1 year-old-group has the highest risk of renal and urinary disorders. The signal of renal and urinary disorders was significant in the group\u2005&lt;10\u2009kg. Vancomycin is related to nephrotoxicity, skin reaction, and rare immune diseases in pediatric patients, especially in low-birth-weight infants and adolescents. Strengthening therapeutic drug monitoring and individualized medication strategies and paying attention to the influence of gender and geographical differences on AE reports is necessary. This study provides data support for optimizing the safety management of vancomycin in children; however, prospective research is necessary to verify the clinical significance of the FDA Adverse Event Reporting System signal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049064","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:47Z","timestamp":1780718507000},"page":"e49064","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating adverse reaction signals of vancomycin in pediatric patients: A FAERS database analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Xue","family":"Li","sequence":"first","affiliation":[{"name":"Graduate Student of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"},{"name":"Henan Hospital of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Chengde County Traditional Chinese Medicine Hospital, Chengde, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1188-8132","authenticated-orcid":false,"given":"Jianghong","family":"Hou","sequence":"additional","affiliation":[{"name":"Graduate Student of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China"},{"name":"Henan Hospital of Traditional Chinese Medicine, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/cid\/cit112","article-title":"Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1\u2009mg\/L: a matched cohort study.","volume":"56","author":"Murray","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/pharmaceutics14040714","article-title":"Efficacy and safety of daptomycin versus vancomycin for bacteremia caused by methicillin-resistant staphylococcus aureus with vancomycin minimum inhibitory concentration > 1 \u03bcg\/mL: a systematic review and meta-analysis.","volume":"14","author":"Samura","year":"2022","journal-title":"Pharmaceutics"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1208\/s12248-021-00577-x","article-title":"Dosing recommendations for vancomycin in children and adolescents with varying levels of obesity and renal dysfunction: a population pharmacokinetic study in 1892 children aged 1\u201318 years.","volume":"23","author":"Smit","year":"2021","journal-title":"AAPS J"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA adverse event reporting system (FAERS).","volume":"9","author":"Yu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"119010","DOI":"10.1016\/j.jep.2024.119010","article-title":"Ginkgo biloba extract safety: insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events.","volume":"337","author":"Yao","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"R7-20260711","doi-asserted-by":"crossref","first-page":"04101","DOI":"10.7189\/jogh.13.04101","article-title":"Understanding and reporting odds ratios as rate-ratio estimates in case-control studies.","volume":"13","author":"Kerr","year":"2023","journal-title":"J Glob Health"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14740338.2024.2359615","article-title":"Real-world safety profile of tetracyclines in children younger than 8 years old: an analysis of FAERS database and review of case report.","volume":"23","author":"Dou","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1192\/j.eurpsy.2023.2474","article-title":"Postmarket safety profile of suicide\/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis.","volume":"66","author":"Chen","year":"2023","journal-title":"Eur Psychiatry"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1038\/s41598-024-67209-0","article-title":"Cardiac adverse events associated with lacosamide: a disproportionality analysis of the FAERS database.","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"e70389","DOI":"10.1002\/sim.70389","article-title":"Bayesian sample size calculations for external validation studies of risk prediction models.","volume":"45","author":"Sadatsafavi","year":"2026","journal-title":"Stat Med"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jpc.14683","article-title":"Vancomycin therapeutic drug monitoring in paediatrics.","volume":"56","author":"Patel","year":"2020","journal-title":"J Paediatr Child Health"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/toxins13100677","article-title":"Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments.","volume":"13","author":"Ahmad-Mansour","year":"2021","journal-title":"Toxins (Basel)"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13312-022-2419-3","article-title":"Clinical profile of children with cystic fibrosis surviving through adolescence and beyond.","volume":"59","author":"Kumar","year":"2022","journal-title":"Indian Pediatr"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/archdischild-2023-325668","article-title":"Inflammatory bowel disease: recent developments.","volume":"109","author":"Ashton","year":"2024","journal-title":"Arch Dis Child"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pop.2021.04.005","article-title":"Congenital heart disease.","volume":"48","author":"Scott","year":"2021","journal-title":"Prim Care"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"e145933","DOI":"10.5812\/ijpr-145933","article-title":"Comparison of the areas under the curve of vancomycin continuous vs. intermittent infusion in critically Ill pediatrics: a randomized clinical trial.","volume":"23","author":"Roshan","year":"2024","journal-title":"Iran J Pharm Res"},{"key":"R18-20260711","article-title":"Therapeutic drug monitoring of vancomycin in the case of augmented renal clearance: a case report of a paediatric patient.","author":"Memi\u015f","year":"2024","journal-title":"Eur J Hosp Pharm"},{"key":"R19-20260711","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcrc.2019.05.002","article-title":"Influence of systemic hemodynamics on microcirculation during sepsis.","volume":"52","author":"Collet","year":"2019","journal-title":"J Crit Care"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"3977585","DOI":"10.1155\/2022\/3977585","article-title":"Postoperative pulmonary hemodynamics and systemic inflammatory response in pediatric patients undergoing surgery for congenital heart defects.","volume":"2022","author":"Souza","year":"2022","journal-title":"Mediators Inflamm"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"e0202439","DOI":"10.1371\/journal.pone.0202439","article-title":"Vancomycin associated acute kidney injury in pediatric patients.","volume":"13","author":"Moffett","year":"2018","journal-title":"PLoS One"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:01:58Z","timestamp":1783778518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":21,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049064","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}